Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 79929-004

7 FDA label images from Naari Pte Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 79929-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levonorgestrel Ethinyl Estradiol Str)

Chemical Structure (Levonorgestrel Ethinyl Estradiol Str)
Chemical structure diagrams of the active ingredients Levonorgestrel and Ethinyl Estradiol as shown for the product Levonorgestrel and Ethinyl Estradiol.*
FDA Label Image

Fig 1 Tab 1 (Levonorgestrel Ethinyl Estradiol Fig1)

Fig 1 Tab 1 (Levonorgestrel Ethinyl Estradiol Fig1)
This image shows two line graphs depicting the concentration of Levonorgestrel and Ethinyl Estradiol in the blood over time (hours). The left graph measures Levonorgestrel concentration in ng/mL, and the right graph shows Ethinyl Estradiol concentration in pg/mL. Data points represent Day 1, Day 6, and Day 21, with error bars indicating variability.*
FDA Label Image

Table 3 (Levonorgestrel Ethinyl Estradiol Fig2)

Table 3 (Levonorgestrel Ethinyl Estradiol Fig2)
A bar chart titled 'Circulatory Disease Mortality Rates Per 100,000 Woman Years by Age, Smoking Status and Oral-Contraceptive Use.' The chart compares mortality rates across four age groups (15-24, 25-34, 35-44, 45+) for four categories: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers). Mortality rates increase with age, with the highest rates observed in ever-users who are smokers, especially in the 45+ age group.*
FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
A forest plot titled 'Risk of Breast Cancer with Combined Oral Contraceptive Use' comparing effect estimates (OR/RR) from multiple studies. The chart shows point estimates with 95% confidence intervals for both 'Ever use' and 'Current use' of combined oral contraceptives across different cohort studies from 2002 to 2017. The x-axis ranges from -1.5 to 2 and the studies are listed on the left with corresponding effect measures on the right.*
FDA Label Image

Order (Blister 1)

Order (Blister 1)
Blister card for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg from Naari Pte Limited. The card contains 28 tablet slots arranged in four weeks, each week having seven days labeled Sunday through Saturday. Storage instructions specify controlled room temperature and keeping out of children's reach. Spaces for lot number and expiration date are on the right side.*
FDA Label Image

Order (Blister 2)

Order (Blister 2)
Blister card packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg strength. The card contains 28 tablets organized in a 4-week, 7-day weekly layout, with days of the week labeled from Sunday to Saturday. The label indicates the product is by Naari Pte Ltd., made in India, with storage instructions to keep at controlled room temperature 20°C to 25°C (68°F to 77°F) and out of reach of children.*
FDA Label Image

Outer Carton (Levo Ee Carton)

Outer Carton (Levo Ee Carton)
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg, a kit containing 3 blister cards with 28 tablets total. The label includes the NDC 79929-004-07 and states the drug is intended to prevent pregnancy. Manufacturer is Naari Pte Limited. Dosage and storage details are also printed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.